Add (deduct) items not involving cash:
Amortization of:
capital assets 317,780 387,274
intangible assets 6,748,787 9,477,808
leasehold inducement (11,432) -
Leasehold inducement - 102,888
Write-off of research inventory 387,667 296,687
Recovery of future income taxes (2,729,422) (1,097,521)
Stock-based compensation expense 1,002,480 405,699
Equity loss in ENI - 477,723
(Gain) losses of company transferred under
contractual arrangement (400,000) 618,922
Loss on disposal of capital assets and assets
held for sale 45,073 58,034
Management fees from ENI - (239,930)
Foreign exchange loss (gain) 8,583 (36,012)
Net change in operating assets and liabilities 6,792,452 232,953
-------------------------------------------------------------------------
Cash used in operating activities (4,799,822) (12,333,565)
-------------------------------------------------------------------------
INVESTING ACTIVITIES
Maturity of short-term investments 108,271,169 21,034,531
Purchase of short-term investments (130,361,807) (17,781,638)
Proceeds from disposal of short-term
investments 30,738 -
Acquisition of Protana assets - (3,109,756)
Proceeds from assets held for sale 265,401 2,118,220
Investment in ENI
'/>"/>
| SOURCE Transition Therapeutics Inc. Copyright©2007 PR Newswire. All rights reserved |